D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 122 Citations 63,691 562 World Ranking 1925 National Ranking 198

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Schizophrenia
  • Dopamine

Psychosis, Neuroscience, Dopamine receptor D2, Schizophrenia and Antipsychotic are his primary areas of study. Shitij Kapur focuses mostly in the field of Psychosis, narrowing it down to topics relating to Dopamine and, in certain cases, Salience. His Dopamine receptor D2 study incorporates themes from Haloperidol, Risperidone, Clozapine and Pharmacology.

He works mostly in the field of Haloperidol, limiting it down to topics relating to Anesthesia and, in certain cases, Quetiapine. His research on Schizophrenia concerns the broader Psychiatry. His Olanzapine research extends to the thematically linked field of Antipsychotic.

His most cited work include:

  • Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia. (1857 citations)
  • The Dopamine Hypothesis of Schizophrenia: Version III—The Final Common Pathway (1707 citations)
  • Hemispheric encoding/retrieval asymmetry in episodic memory: positron emission tomography findings (1352 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Schizophrenia, Internal medicine, Psychiatry, Antipsychotic and Neuroscience. His Schizophrenia research integrates issues from Positron emission tomography, Psychosis, Cognition and Clinical psychology. His Internal medicine research is multidisciplinary, incorporating perspectives in Placebo, Endocrinology and Atypical antipsychotic.

His studies in Psychiatry integrate themes in fields like Randomized controlled trial and Clinical trial. The various areas that Shitij Kapur examines in his Antipsychotic study include Clozapine, Haloperidol, Olanzapine, Risperidone and Pharmacology. Dopamine covers Shitij Kapur research in Dopamine receptor D2.

He most often published in these fields:

  • Schizophrenia (34.25%)
  • Internal medicine (36.38%)
  • Psychiatry (26.94%)

What were the highlights of his more recent work (between 2012-2021)?

  • Schizophrenia (34.25%)
  • Psychiatry (26.94%)
  • Psychosis (28.46%)

In recent papers he was focusing on the following fields of study:

Shitij Kapur focuses on Schizophrenia, Psychiatry, Psychosis, Internal medicine and Neuroscience. His work deals with themes such as Anterior cingulate cortex, Dopamine, Clinical psychology, Positron emission tomography and Depression, which intersect with Schizophrenia. His Psychosis study deals with Glutamate receptor intersecting with Neuroimaging.

His research in Internal medicine intersects with topics in Endocrinology, Placebo, Olanzapine, Antipsychotic and Positive and Negative Syndrome Scale. His research integrates issues of Haloperidol, Aripiprazole, Dopamine receptor D2, First episode and First episode psychosis in his study of Antipsychotic. His study on Basal ganglia is often connected to PDE10A as part of broader study in Neuroscience.

Between 2012 and 2021, his most popular works were:

  • CNVs conferring risk of autism or schizophrenia affect cognition in controls (459 citations)
  • Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment (261 citations)
  • Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function. (186 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Schizophrenia
  • Dopamine

Shitij Kapur mostly deals with Schizophrenia, Internal medicine, Psychiatry, Psychosis and Neuroscience. His biological study spans a wide range of topics, including Major depressive disorder, Depression, Genetics and Clinical psychology. The study incorporates disciplines such as Antipsychotic, Placebo, Endocrinology and Positive and Negative Syndrome Scale in addition to Internal medicine.

His work carried out in the field of Psychiatry brings together such families of science as Placebo-controlled study, Clinical trial and Affect. His Psychosis research is multidisciplinary, incorporating elements of Jumping to conclusions, Cognitive bias, Distress, Case-control study and First episode. His research on Neuroscience often connects related areas such as Huntingtin.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia.

Shitij Kapur.
American Journal of Psychiatry (2003)

2902 Citations

The Dopamine Hypothesis of Schizophrenia: Version III—The Final Common Pathway

Oliver D. Howes;Shitij Kapur.
Schizophrenia Bulletin (2009)

2755 Citations

Hemispheric encoding/retrieval asymmetry in episodic memory: positron emission tomography findings

Endel Tulving;Shitij Kapur;Fergus I. M. Craik;Morris Moscovitch.
Proceedings of the National Academy of Sciences of the United States of America (1994)

2213 Citations

Grand challenges in global mental health

Pamela Y. Collins;Vikram Patel;Vikram Patel;Sarah S. Joestl;Dana March;Dana March.
(2011)

2146 Citations

Does Fast Dissociation From the Dopamine D2 Receptor Explain the Action of Atypical Antipsychotics?: A New Hypothesis

Shitij Kapur;Philip Seeman.
American Journal of Psychiatry (2001)

1516 Citations

Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia

Shitij Kapur;Robert Zipursky;Corey Jones;Gary Remington.
American Journal of Psychiatry (2000)

1341 Citations

Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it

S Kapur;A G Phillips;T R Insel.
Molecular Psychiatry (2012)

1168 Citations

The Maudsley Prescribing Guidelines in Psychiatry

David Taylor;Carol Paton;Shitij Kapur;South London.
(2007)

1099 Citations

Serotonin-dopamine interaction and its relevance to schizophrenia

Shitij Kapur;Gary Remington.
American Journal of Psychiatry (1996)

1096 Citations

The nature of dopamine dysfunction in schizophrenia and what this means for treatment

Oliver D. Howes;Joseph Kambeitz;Euitae Kim;Daniel Stahl.
Archives of General Psychiatry (2012)

1051 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Shitij Kapur

Oliver D. Howes

Oliver D. Howes

King's College London

Publications: 262

Gary Remington

Gary Remington

Centre for Addiction and Mental Health

Publications: 224

Philip McGuire

Philip McGuire

King's College London

Publications: 184

Jim van Os

Jim van Os

University Medical Center Utrecht

Publications: 179

Robin M. Murray

Robin M. Murray

King's College London

Publications: 177

Alan A. Wilson

Alan A. Wilson

Centre for Addiction and Mental Health

Publications: 138

Ole A. Andreassen

Ole A. Andreassen

Oslo University Hospital

Publications: 117

Ariel Graff-Guerrero

Ariel Graff-Guerrero

Centre for Addiction and Mental Health

Publications: 110

Sylvain Houle

Sylvain Houle

University of Toronto

Publications: 102

Matcheri S. Keshavan

Matcheri S. Keshavan

Beth Israel Deaconess Medical Center

Publications: 96

Paolo Fusar-Poli

Paolo Fusar-Poli

King's College London

Publications: 95

René S. Kahn

René S. Kahn

Icahn School of Medicine at Mount Sinai

Publications: 94

Zafiris J. Daskalakis

Zafiris J. Daskalakis

University of California - San Diego School of Medicine

Publications: 94

John M. Kane

John M. Kane

Zucker Hillside Hospital

Publications: 91

Christoph U. Correll

Christoph U. Correll

Charité - University Medicine Berlin

Publications: 89

Raymond J. Dolan

Raymond J. Dolan

University College London

Publications: 86

Trending Scientists

Torgeir Dingsøyr

Torgeir Dingsøyr

Norwegian University of Science and Technology

Gordon Wilfong

Gordon Wilfong

Nokia (United States)

Yair Amir

Yair Amir

Johns Hopkins University

Fabio Pellizzer

Fabio Pellizzer

Micron (United States)

Katarina Edwards

Katarina Edwards

Uppsala University

Roberto Cammi

Roberto Cammi

University of Parma

Lluís Mañosa

Lluís Mañosa

University of Barcelona

Peter Model

Peter Model

Rockefeller University

I. H. Kim

I. H. Kim

Dankook University

Colin R. Black

Colin R. Black

University of Nottingham

Colin M. Dundas

Colin M. Dundas

United States Geological Survey

Ping-Chang Yang

Ping-Chang Yang

Shenzhen University

Allan McI. Mowat

Allan McI. Mowat

University of Glasgow

Erik W. Thompson

Erik W. Thompson

Queensland University of Technology

David Amiel

David Amiel

University of California, San Diego

Félix Carvalho

Félix Carvalho

University of Porto

Something went wrong. Please try again later.